Development of animal models to study aggressive thyroid cancers.

Area of Science:

• Oncology
• Genetics
• Translational Research

Background:

• Mouse models are crucial for understanding thyroid cancer development and treatment.
• Early models used chemical or radiation carcinogenesis, limiting mechanistic insights.
• Advances in genetic engineering allow for thyroid-specific expression of driver mutations.

Purpose of the Study:

• To review recent advancements in mouse models for advanced thyroid cancer.
• To highlight models incorporating cooperating mutations alongside oncogenic drivers.
• To emphasize the utility of these models in preclinical therapy research.

Main Methods:

• Development of genetically engineered mouse models (GEMMs) with thyroid-specific oncogenic drivers.
• Incorporation of cooperating mutations identified in advanced human thyroid cancers.
• Utilizing these models to study tumor progression and therapeutic responses.

Main Results:

• Driver mutations alone are often insufficient for advanced cancer progression.
• Cooperating mutations, in conjunction with drivers, promote thyroid tumor progression and invasion.
• GEMMs with combined alterations effectively recapitulate advanced thyroid cancer phenotypes.

Conclusions:

• Genetically engineered mouse models combining oncogenic drivers and cooperating mutations are vital preclinical tools.
• These advanced models enhance the study of molecular pathways in advanced thyroid cancer.
• They facilitate the exploration of therapeutic strategies targeting driver mutations and cooperating alterations.